A new stem cell therapy has repaired blinding damage to the cornea in 93% of patients in an early clinical trial.The cornea ...

Results from a Mass Eye and Ear-led phase 1/2 clinical trial of a novel stem cell treatment for cornea injuries found 14 ...

A new stem cell therapy, CALEC, has demonstrated a 92% success rate in regenerating corneas and restoring vision. This ...

In the context of a clinical trial, double-blind means that neither the patients nor the researchers know who is getting a placebo and who is getting the treatment. Because patients don't know ...

Stem cells from a healthy eye, when transplanted into a damaged eye, safely restored corneal surfaces in 14 patients who were followed for 18 months.

Benzodiazepines are largely accepted as being the first pharmacotherapeutic approach in the treatment of GAD. Lader [16] stated that for short-term treatment up to 4 weeks, the benzodiazepines are ...

TIXiMED Inc. ( a clinical-stage pharmaceutical company based on the breakthrough discovery that TXNIP plays an important role in the ...

- Elumina is a Phase 2, multicenter, double-blind, randomized, placebo-controlled, clinical trial to assess the efficacy, ...

A new stem cell therapy has repaired blinding damage to the cornea in 93% of patients in an early clinical trial. However, severe injuries, such as those caused by chemical burns or infections ...

An expanded phase clinical trial that tested a groundbreaking, experimental stem cell treatment for blinding cornea injuries ...

Methods: Multicentre, randomised, double-blind, parallel-group clinical trial in 64 outpatients with GAD (DSM-IV criteria). Patients were assigned to mexazolam 1mg three times daily (n = 32 ...